FundedIQ
Biotechnology

ProtonDx: Funding, Investors & Team (Oct 2026)

ProtonDx is a diagnostic platform that provides molecular testing services. They combine speed, sensitivity, specificity, and convenience to differentiate and detect multiple pathogens from the sample. They respond to customer inquiries by contact form and email.

protondx.com LinkedIn London, United Kingdom 11-50 employees
Biotechnology Consulting Health Care Health Diagnostics B2B
Total raised
$1.0M
Rounds
1
Latest
Seed
Dec 2025

ProtonDx has raised $1.0M across 1 funding round on record, the most recent a Seed of $1.0M announced in Dec 2025.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

ProtonDx Company Profile and Key Stats

Total funding raised
$1.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$1.0M in Dec 2025
Employees
11-50
reported band
Headquarters
London, United Kingdom

Latest funding round on record: Dec 2025.

ProtonDx Funding Rounds

Date
Round
Amount
Seed
$1.0M

ProtonDx Founders and Leadership Team

Name
Role
Contact
Jesus Rodriguez Manzano
Founder
Locked

Contact details for the ProtonDx team: 1 of 1 has an email address on file.

Start 14-day free trial →

ProtonDx Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
5,368
$4.1M
17,153
$3.1M

ProtonDx's latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like ProtonDx in Biotechnology and London

Companies Similar to ProtonDx

Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…

Series C $40.4M

OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…

Series C $310M

HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…

Series A $8.0M

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

ProtonDx Funding FAQs

What does ProtonDx do?

ProtonDx is a diagnostic platform that provides molecular testing services. They combine speed, sensitivity, specificity, and convenience to differentiate and detect multiple pathogens from the sample. They respond to customer inquiries by contact form and email.

How much funding has ProtonDx raised?

ProtonDx has raised $1.0M across 1 round on record. The most recent is a Seed of $1.0M announced in Dec 2025.

When did ProtonDx last raise funding?

ProtonDx's most recent funding round on record is a Seed of $1.0M, announced in Dec 2025.

Who founded ProtonDx?

FundedIQ lists Jesus Rodriguez Manzano (Founder) at ProtonDx.

Where is ProtonDx headquartered?

ProtonDx is based in London, England, United Kingdom.

How many employees does ProtonDx have?

ProtonDx is in the 11-50 employee band.

How does ProtonDx's funding compare to other Biotechnology startups?

ProtonDx's latest round of $1.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's ProtonDx Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ProtonDx is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.